Clin2
NCT07301216Possibly a fitRecruiting

Copper in urine after stopping Wilson disease therapy

Wilson Disease

Part of Brain & nervous system, Digestive system, Genetic & congenital, Hormones & metabolism clinical trials.

This study is looking at what happens to copper levels in the urine when people with Wilson disease briefly stop their medicine. It may help doctors understand how well your body controls copper without treatment.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You must have Wilson disease, confirmed by a Leipzig score of 4 or higher.
  • You need to have been on Wilson disease treatment for at least 1 year.
  • Your liver and kidney function should be stable and within certain limits (your doctor can check this).
  • You should not have changed your Wilson disease medication in the last 6 months.
  • If you are of childbearing age, you must have a negative pregnancy test before stopping your medicine.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT03334292Recruiting
Study of the natural course of Wilson disease

This study follows people who already have Wilson disease to understand how the condition changes over time. It may help researchers better predict future symptoms and improve care.

New Haven, Connecticut
NCT06430359Recruiting
How urine copper changes over 24 hours in Wilson disease

This study looks at how copper levels in urine change throughout the day and night in people with Wilson disease. If you take part, you will collect all your urine for 24 hours so researchers can measure copper at different times.

Bron, Rhone
NCT04965545Recruiting
Tests for diagnosing Wilson disease using special lab findings

This trial is for people who already have a genetic diagnosis of Wilson disease. It looks at whether specific lab tests and a physical eye finding can help confirm and support the diagnosis.

Hangzhou, Zhejiang
NCT07159581Enrolling by invitation
Gene therapy for Wilson disease study with PET scans

This trial uses a special PET scan with a copper tracer to see how well gene therapy is working in people with Wilson disease. It may help doctors understand if the treatment is helping your body handle copper properly.

Aarhus, Aarhus N
NCT06650319Recruiting· Early Phase 1
Testing LY-M003 injection for Wilson disease

This study tests an injection called LY-M003 for people with Wilson disease who have already been treated with standard medicines. The goal is to see if it is safe and works for them.

Hangzhou, Zhejiang
NCT07075393Not yet recruiting
Kidney health in Wilson's disease

This study looks at how Wilson's disease affects the kidneys. It aims to better understand kidney problems in people with Wilson's disease, which could help improve care.

Paris

Hear when a new Wilson Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.